Corporate Banner
Satellite Banner
Medicinal Chemistry
Scientific Community
Become a Member | Sign in
Home>Events>This Event
  Events - May 2013

3-day Agilent H4063A Mass Spectral Interpretation course

13 May 2013 - 15 May 2013 - Milton Keynes, UK

Bookmark and Share

What will I learn on this course?

This three-day course is designed to present the fundamental concepts necessary to obtain high-quality data in SCAN mode from a GC-MS System for spectral interpretation purposes. The most commonly employed tools used in identifying compounds based on their mass spectra are introduced, the physical reasons for their efficiency explained, and their use reinforced through problem solving. The most common decomposition mechanisms responsible for fragment ions will also be introduced. This course is classroom based and combines a mixture of presentations to introduce the concepts with a high proportion of lab exercises to reinforce the knowledge.

If you wish to delve further into mass spectrometry in order to identify unknown spectra and evaluate MS library database search results using a modern mass spectrometer and data system, then this course for you. This provides only an introduction to mass spectral interpretation. 

Is this course for me?

This course is recommended for those who have a good background in organic chemistry and at least six months experience as a GC-MS operator 

Course Venue

Agilent Centre of Excellence, The Open University, Milton Keynes, UK

More Information

For more information or a course outline, please email

Further information
Scientific News
Drug May Prevent Life-Threatening Muscle Loss in Advanced Cancers
New data describes how an experimental drug can stop life-threatening muscle wasting (cachexia) associated with advanced cancers and restore muscle health.
Chemical Design Made Easier
Rice University scientists prepare elusive organocatalysts for drug and fine chemical synthesis.
Nanocarriers May Carry New Hope for Brain Cancer Therapy
Berkeley lab researchers develop nanoparticles that can carry therapeutics across the brain blood barrier.
Potential Persistent Tuberculosis Treatment
Researchers have discovered several first-in-class compounds that target hidden TB infections by attacking a critical process the bacteria use to survive in the hostile environment of the lungs.
Shedding Light on “Dark” Cellular Receptors
UNC and UCSF labs create a new research tool to find homes for two orphan cell-surface receptors, a crucial step toward finding better therapeutics and causes of drug side effects.
Giant Molecules Inhibit Ebola Infection
European researchers have designed a "giant" molecule formed by thirteen fullerenes covered by carbohydrates which, by blocking this receptor, are able to inhibit the cell infection by an artificial ebola virus model.
First Therapy Appearing to Reverse Decline in Parkinson’s
An FDA-approved drug for leukemia improved cognition, motor skills and non-motor function in patients with Parkinson’s disease and Lewy body dementia in a small clinical trial, say researchers at Georgetown University Medical Center (GUMC).
Fighting Pain with Ketamine
Researchers at the Texas A&M Health Science Center are using ketamine, a drug that already exists as an anesthetic, to treat pain.
Possible New Treatment for Neurodegenerative Diseases Found
Researchers at the University of Liverpool have found that a well-established anti-epileptic drug could also be used as a treatment for neurodegenerative diseases.
Breast Cancer Drug Beats Superbug
Tamoxifen helps white blood cells clear multidrug-resistant bacteria in lab and mouse studies.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos